Paucity of bulbar function measures in inclusion body myositis trials. Reply to: Current status of clinical outcome measures in inclusion body myositis: a systematised review

K. L. Garand; G. A. Malandraki; K. L. Stipancic; E. Kearney; B. Roy; L. N. Alfano

doi:10.55563/clinexprheumatol/x66elf

Paucity of bulbar function measures in inclusion body myositis trials. Reply to: Current status of clinical outcome measures in inclusion body myositis: a systematised review

K. L. Garand
, G. A. Malandraki
, K. L. Stipancic
, E. Kearney
, B. Roy
, L. N. Alfano

Communicative Disorders and Sciences

University at Buffalo

University of Pittsburgh
Purdue University
Queensland University of Technology
Yale University
Nationwide Children’s Hospital
Ohio State University

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	399
Number of pages	1
Journal	Clinical and Experimental Rheumatology
Volume	41
Issue number	2
DOIs	https://doi.org/10.55563/clinexprheumatol/x66elf
State	Published - Feb 2023

Access to Document

10.55563/clinexprheumatol/x66elf

Cite this

Garand, K. L., Malandraki, G. A., Stipancic, K. L., Kearney, E., Roy, B., & Alfano, L. N. (2023). Paucity of bulbar function measures in inclusion body myositis trials. Reply to: Current status of clinical outcome measures in inclusion body myositis: a systematised review. Clinical and Experimental Rheumatology, 41(2), 399. https://doi.org/10.55563/clinexprheumatol/x66elf

@article{99dceb51a53847a59efa1d59184df357,

title = "Paucity of bulbar function measures in inclusion body myositis trials. Reply to: Current status of clinical outcome measures in inclusion body myositis: a systematised review",

author = "Garand, \{K. L.\} and Malandraki, \{G. A.\} and Stipancic, \{K. L.\} and E. Kearney and B. Roy and Alfano, \{L. N.\}",

year = "2023",

month = feb,

doi = "10.55563/clinexprheumatol/x66elf",

language = "English",

volume = "41",

pages = "399",

journal = "Clinical and Experimental Rheumatology",

issn = "0392-856X",

publisher = "Clinical and Experimental Rheumatology S.A.S.",

number = "2",

}

Garand, KL, Malandraki, GA, Stipancic, KL, Kearney, E, Roy, B & Alfano, LN 2023, 'Paucity of bulbar function measures in inclusion body myositis trials. Reply to: Current status of clinical outcome measures in inclusion body myositis: a systematised review', Clinical and Experimental Rheumatology, vol. 41, no. 2, pp. 399. https://doi.org/10.55563/clinexprheumatol/x66elf

Paucity of bulbar function measures in inclusion body myositis trials. Reply to: Current status of clinical outcome measures in inclusion body myositis: a systematised review. / Garand, K. L.; Malandraki, G. A.; Stipancic, K. L. et al.
In: Clinical and Experimental Rheumatology, Vol. 41, No. 2, 02.2023, p. 399.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Paucity of bulbar function measures in inclusion body myositis trials. Reply to

T2 - Current status of clinical outcome measures in inclusion body myositis: a systematised review

AU - Garand, K. L.

AU - Malandraki, G. A.

AU - Stipancic, K. L.

AU - Kearney, E.

AU - Roy, B.

AU - Alfano, L. N.

PY - 2023/2

Y1 - 2023/2

UR - https://www.scopus.com/pages/publications/85149176232

U2 - 10.55563/clinexprheumatol/x66elf

DO - 10.55563/clinexprheumatol/x66elf

M3 - Letter

C2 - 36700648

SN - 0392-856X

VL - 41

SP - 399

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

IS - 2

ER -

Paucity of bulbar function measures in inclusion body myositis trials. Reply to: Current status of clinical outcome measures in inclusion body myositis: a systematised review

Access to Document

Other files and links

Fingerprint

Cite this